SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0269881107081519v1
22/5/567    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Snigdha, S.
Right arrow Articles by Neill, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Snigdha, S.
Right arrow Articles by Neill, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats

S. Snigdha

Bradford School of Pharmacy, University of Bradford, Bradford, West Yorkshire, UK, ssnigdha{at}brad.ac.uk

C. Thumbi

Bradford School of Pharmacy, University of Bradford, Bradford, West Yorkshire, UK

GP Reynolds

Division of Psychiatry and Neuroscience, Queen's University Belfast, Whitla Medical Building, Belfast, UK

JC Neill

Bradford School of Pharmacy, University of Bradford, Bradford, West Yorkshire, UK

Weight gain induced by some second-generation anti—psychotics such as olanzapine has emerged as a most debilitating side-effect. This study investigates whether co-administration with either ziprasidone or aripiprazole, which have little propensity to induce weight gain, can attenuate the hyperphagic effect of olanzapine. Female hooded-Lister rats (n = 8 per group) were treated acutely with either vehicle, olanzapine (1 mg/kg), ziprasidone (1 mg/kg), aripiprazole (2 mg/kg) or olanzapine in combination with ziprasidone or aripiprazole and placed in automated locomotor activity (LMA) boxes with preweighed palatable mash. Food intake and LMA were measured for 60 min postdrug treatment. All olanzapine-treated groups demonstrated significant increases in food intake (P < 0.001). This effect was attenuated following co-administration of olanzapine with either ziprasidone or aripiprazole (P < 0.001), neither of which affected food intake alone. The lack of hyperphagia induced by aripiprazole and ziprasidone may reflect an inherent pharmacological mechanism preventing weight gain.

Key Words: antipsychotics • ziprasidone • aripiprazole • olanzapine • hyperphagia • rats

This version was published on July 1, 2008

Journal of Psychopharmacology, Vol. 22, No. 5, 567-571 (2008)
DOI: 10.1177/0269881107081519
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement